Business · 28/01/2013Updated: 10/17/2026 · 1 min read

FDA Hosts Public Conference on Detecting and Evaluating Drug-Induced Liver Injury

The FDA, in collaboration with C-Path and PhRMA, is hosting a public conference to discuss strategies for detecting and assessing liver injury caused by prescription medications, with input from industry, academia, healthcare providers, patient groups, and regulatory agencies.